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Objectives. We investigated endocrine correlates of the hemo-
dynamic changes induced by carbon dioxide pneumoperitoneum
(PNO). We then studied whether clonidine might modulate the
hemodynamic changes induced by PNO by reducing release of
catecholamines and vasopressin.
Background. Both mechanical and neurohumoral factors con-
tribute to the hemodynamic changes induced by carbon dioxide
PNO. Several mediators have been proposed, but no study has
correlated hemodynamic changes with changes in levels of these
potential mediators.
Methods. We conducted two studies, each including 20 healthy
patients scheduled for elective laparoscopic cholecystectomy. In
the first study serial measurements of hemodynamics (thermodi-
lution technique) were done during laparoscopy and after exsuf-
flation. Plasma concentrations of cortisol, catecholamines, vaso-
pressin, renin, endothelin and prostaglandins were measured at
the same time points. In the second study patients were randomly
allocated to receive 8 mg/kg clonidine infused over 1 h or placebo
before PNO. Hemodynamics and plasma levels of cortisol, cat-
echolamines and vasopressin were measured during PNO and
after exsufflation.
Results. Peritoneal insufflation resulted in a significant reduc-
tion of cardiac output (18 6 4%) and increases in mean arterial
pressure (39 6 8%) and systemic (70 6 12%) and pulmonary
(98 6 18%) vascular resistances. Laparoscopy resulted in pro-
gressive and significant increases in plasma concentrations of
cortisol, epinephrine, norepinephrine and renin. Vasopressin
plasma concentrations markedly increased immediately after the
beginning of PNO (before PNO 6 6 4 pg/ml; during PNO 129 6
42 pg/ml; p < 0.05). The profile of vasopressin release paralleled
the time course of changes in systemic vascular resistance.
Prostaglandins and endothelin did not change significantly.
Clonidine significantly reduced mean arterial pressure, heart rate
and the increase in systemic vascular resistance. Clonidine also
significantly reduced catecholamine concentrations but did not
alter vasopressin and cortisol plasma concentrations.
Conclusions. Vasopressin and catecholamines probably medi-
ate the increase in systemic vascular resistance observed during
PNO. Clonidine before PNO reduces catecholamine release and
attenuates hemodynamic changes during laparoscopy.
(J Am Coll Cardiol 1998;32:1389–96)
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The multiple benefits reported after laparoscopy explain its
increasing use (1). Consequently, laparoscopy has now become
the standard technique for cholecystectomy. However, the
pneumoperitoneum (PNO) required for laparoscopy results in
pathophysiologic changes (1). More particularly, changes in
cardiovascular function occur during laparoscopy. These are
characterized by an increase in arterial pressure and systemic
and pulmonary vascular resistances (SVR and PVR) early
after the beginning of intraabdominal insufflation, with no
significant changes in heart rate (HR). A 10% to 30% decrease
in cardiac output has also been reported in most studies (1–3).
Both mechanical and neurohumoral factors contribute to
these hemodynamic changes (2,4). Several mediators have
been proposed: catecholamines (5,6), prostaglandins (7), renin
(8) and vasopressin (9–11). Unfortunately, no study has cor-
related hemodynamic changes with changes in levels of these
potential mediators. Therefore, we first investigated endocrine
correlates of the hemodynamic changes induced by PNO
during laparoscopic cholecystectomy in healthy patients. Inter-
estingly, alpha2-adrenergic agonists have been shown to im-
prove hemodynamic stability during gynecologic laparoscopy
(12,13). Moreover, clonidine inhibits the release of cat-
echolamines (14) and also blocks the release of vasopressin in
dogs (15). We therefore tested the hypothesis that clonidine
might attenuate the hemodynamic changes induced by PNO by
reducing release of these substances.
Methods
Two studies were conducted after our institution’s Ethics
Committee gave approval and after patients gave their in-
formed consent. Patients in each study were scheduled for
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elective laparoscopic cholecystectomy. Inclusion criteria were
body weight no more than 20% above ideal weight, age
between 18 and 70 years, absence of acute cholecystitis and no
cardiorespiratory disease or medications. We used the same
anesthetic technique in both studies. All patients were given
50 mg hydroxyzine orally 2 h before surgery and an intramus-
cular injection of 5 mg midazolam and 0.25 mg atropine before
transfer to surgery. General anesthesia was induced with 15 mg
sufentanil and 5 mg/kg thiopental. After orotracheal intuba-
tion facilitated with 0.5 mg/kg atracurium, anesthesia was
maintained with 50% nitrous oxide in oxygen and isoflurane.
Isoflurane concentrations were adapted to maintain hemody-
namic stability by an experienced anesthesiologist; mean arte-
rial pressure (MAP) was not allowed to increase more than
20% above preinduction value. In addition to clinical signs, the
anesthesiologist used routine monitoring for laparoscopic cho-
lecystectomy (i.e., automated oscillometric arterial blood pres-
sure, electrocardiogram, capnography and pulse oximetry), but
was unaware of the information derived from the invasive
monitoring described below as well as of the arterial blood gas
analyses. During surgery minute ventilation was controlled
(Servo 900C; Siemens Elema, Stockholm, Sweden) and ad-
justed to keep the expired end-tidal partial pressure of carbon
dioxide (PCO2) between 30 and 40 mm Hg. Respiratory rate
was kept constant at 10-min. During laparoscopy intraabdomi-
nal pressure was automatically maintained at 14 mm Hg by a
carbon dioxide insufflator (Richard Wolf; Knittlingen, Germany).
Study 1: Hemodynamic Data and Endocrine Correlates.
Twenty American Society of Anesthesiologists (ASA) patients
in physical status 1 and 2 were included in this study. Fasting
and intraoperative fluid losses were compensated by a contin-
uous intravenous infusion ( 5 mlzkg21zh21) of lactated Ringer’s
solution.
Hemodynamic and metabolic parameters. A radial artery
was cannulated and a 7.5F thermodilution pulmonary artery
catheter was introduced via the right internal jugular vein
before induction of anesthesia. The following parameters were
recorded on a Datex AS/3 monitor (Datex-Engstro¨m, Helsinki,
Finland): MAP, right atrial pressure (RAP), pulmonary artery
pressure and pulmonary capillary wedge pressure (PCWP) as
well as HR. Cardiac output was measured by the Datex AS/3
monitor using the average of three measurements made at the
end of expiration. Systemic vascular resistance and PVR were
automatically computed by the Datex AS/3 monitor. Data were
collected before the induction of anesthesia; 10 min after the
induction of anesthesia; 10 min after tilting into a 10° head-up
position; 5, 15 and 30 min after the beginning of insufflation;
and finally 30 min after exsufflation. At this last time point
anesthesia had been terminated for approximately 15 min and
the patients, extubated, were breathing spontaneously in the
horizontal position. The pressure transducer was located at the
level of the right atrium and was moved after tilting to remain
at this level. At the same time points arterial and mixed venous
blood samples were drawn for blood gas analysis (288 Blood
Gas System; Ciba Corning Diagnostics Corp., Medfield, Mas-
sachusetts). Oxygen transport and oxygen consumption were
calculated according to standard formulas. Plasma lactate
concentrations were also measured (Socolab, Limal, Belgium).
Endocrine parameters. Arterial blood samples were col-
lected at the same time points as above for assay of the
following hormones: cortisol (Radim, Lie`ge, Belgium); cat-
echolamines (16); renin (ERIA Diagnostics Pasteur, Marne la
Coquette, France); endothelin (Amersham International, Am-
ersham, United Kingdom); vasopressin (Bu¨hlmann Laborato-
ries AG, Basel, Switzerland); vasopressin–neurophysin (17);
and prostaglandin E2 (PGE2), 6-keto-PGF1a (a metabolite of
prostacyclin) and TxB2 (a metabolite of thromboxane) (Cay-
man Chemical, Ann Arbor, Michigan). Cortisol was used as an
index of intraoperative stress; the other hormones were se-
lected for their known vasoactive properties. Vasopressin–
neurophysin, released concomitantly with vasopressin, is more
stable in the blood than the active nonapeptide. The assay of
the inactive peptide was used to validate measured plasma
concentrations of vasopressin.
Study 2: Effects of Clonidine on Hemodynamic and Endo-
crine Changes. After the induction of anesthesia, 20 ASA
physical status 1 and 2 patients were randomly allocated to
receive either 8 mgzkg21 clonidine intravenously over 1 h or the
same volume of saline placebo in a double-blind fashion. This
dose of clonidine was selected to approach doses reported to
inhibit vasopressin release in animal studies (15). To avoid
potential severe hypotension as a result of clonidine treatment,
all patients received 500 ml lactated Ringer’s solution before
the induction of anesthesia and peritoneal insufflation was
initiated with the patient in the horizontal position. Intraoper-
atively, the intravenous infusion of lactated Ringer’s solution
was 5 mlzkg21zh21. Because invasive monitoring was per-
formed after the induction of anesthesia to avoid patient
discomfort, preoperative cardiac function was assessed, using
transthoracic echocardiography, on the day before surgery by
the same investigator (J.L.C.), who was unaware of the patient
allocation group.
Hemodynamic and metabolic parameters. The same hemo-
dynamic parameters as in the first part of the study were
recorded. Data were collected at the end of the infusion of
clonidine or placebo and before induction of the PNO, 5 min
after the beginning of peritoneal insufflation with the patient in
supine position, 15 and 30 min after the beginning of insuffla-
Abbreviations and Acronyms
ASA 5 American Society of Anesthesiologists
HR 5 heart rate
MAP 5 mean arterial pressure
PCO2 5 partial pressure of carbon dioxide
PCWP 5 pulmonary capillary wedge pressure
PGE2 5 prostaglandin E2
PNO 5 pneumoperitoneum
PVR 5 pulmonary vascular resistance
RAP 5 right atrial pressure
Sv¯O2 5 mixed venous blood oxygen saturation
SVR 5 systemic vascular resistance
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tion with the patient tilted to a 10° head-up position, 5 min
after exsufflation with the patient still tilted to a 10° head-up
position, and finally 30 min after exsufflation, approximately
15 min after the end of anesthesia and tracheal extubation with
the patient in horizontal position breathing spontaneously.
Mixed venous blood oxygen saturation (Sv¯O2) was also mea-
sured at the same time points.
Endocrine parameters. Arterial blood samples were col-
lected at the same time points to assay plasma cortisol,
catecholamine and vasopressin concentrations. Plasma
clonidine concentrations were also assayed 5 min after the
beginning of peritoneal insufflation with the patient in supine
position using a radioimmunoassay. The sensitivity was
0.1 ng/ml with a coefficient of variation of ,15%.
Statistical analysis. Results are reported as mean 6 SEM.
Data were analyzed by one-way analysis of variance for re-
peated measures followed by Scheffe´’s test for multiple com-
parisons (study 1). Because distributions were not normal at
some time points (from 5 min after the beginning of peritoneal
insufflation until approximately 15 min after the end of anes-
thesia extubation) for epinephrine, norepinephrine and vaso-
pressin, analysis was applied after logarithmic transformation.
In the second study demographic data were compared using
the unpaired Student t test. To assess the effect of clonidine,
data were analyzed by two-way analysis of variance for re-
peated measures followed by the Newman–Keuls’ test. Results
were considered to be statistically significant at the 5% critical
level.
Results
Study 1. Morphometric characteristics of the patients
were: age 46 6 5 years, sex (F/M) 14/6, weight 67 6 4 kg and
height 164 6 3 cm. The duration of PNO was 67 6 7 min. After
the induction of anesthesia cardiac output decreased (Table 1).
Tilting the patient to a 10° head-up position resulted in a
significant decrease in RAP and PCWP. Consequently, cardiac
output and MAP further decreased. Peritoneal insufflation at
5 min resulted in a significant reduction (18 6 4%) of cardiac
output, and a rise of MAP (39 6 8%). Right atrial pressure and
PCWP were significantly increased during PNO. Systemic and
pulmonary vascular resistances also increased after peritoneal
insufflation (SVR 70 6 12%, PVR 98 6 18%). Concentrations
of isoflurane were increased to correct the increases in MAP.
Simultaneously, partial correction of cardiac output, SVR and
PVR occurred. However, these variables remained signifi-
cantly different from preoperative values during PNO. After
exsufflation all hemodynamic parameters returned to preoper-
ative values (Table 1).
Changes in oxygen delivery paralleled the changes of car-
diac output. Oxygen consumption was significantly reduced
during anesthesia and surgery, but was significantly increased
30 min after exsufflation. Intraoperatively Sv¯O2 remained
normal (.70%). After exsufflation Sv¯O2 significantly de-
creased. Lactate plasma concentrations progressively and sig-
nificantly increased during laparoscopy, but remained normal
(,2.0 mmol/L) (Table 2).
Five minutes after the beginning of peritoneal insufflation,
PNO rapidly resulted in a marked release of vasopressin and
neurophysin. Plasma concentrations of vasopressin then de-
creased, whereas plasma concentrations of neurophysin pla-
teaued (Fig. 1). The profile of vasopressin release closely
resembled the time course of changes in SVR. Plasma concen-
trations of epinephrine, norepinephrine and renin also in-
creased during laparoscopy, but these changes were more
progressive than the increase in SVR. Plasma concentrations
of cortisol gradually increased during surgery (15 and 30 min
after the beginning of insufflation) and in the immediate
postoperative period. Plasma concentrations of endothelin,
TxB2, 6-keto-PGF1a and PGE2 did not change significantly
(Table 3).
Study 2. Morphometric characteristics of the patients, du-
ration of PNO and preoperative hemodynamic data were
similar in the placebo and the clonidine groups (Table 4). The
infusion of clonidine resulted in a plasma concentration of
clonidine of 4.3 6 0.3 ng/ml at 5 min after the beginning of







Surgery5 min 15 min 30 min
MAP (mm Hg) 97 6 3 90 6 3 74 6 3* 102 6 4† 104 6 4† 93 6 4† 107 6 4†
HR (beatszmin21) 77 6 3 83 6 3 77 6 3 83 6 4 84 6 3 84 6 4 80 6 4
RAP (mm Hg) 8 6 1 9 6 1 6 6 1* 11 6 1† 11 6 1† 10 6 2† 8 6 1
PCWP (mm Hg) 10 6 1 9 6 1 7 6 1* 14 6 1*† 15 6 1*† 13 6 1*† 10 6 1
CO (Lzmin21) 6.0 6 0.3 4.6 6 0.3* 3.6 6 0.2* 3.1 6 0.2*† 4.2 6 0.2* 3.9 6 0.3* 5.9 6 0.4
SVR (dynzszcm25) 1,218 6 56 1,504 6 98 1,561 6 89 2,500 6 198*† 1,836 6 112*† 1,805 6 97* 1,398 6 72
PVR (dynzszcm25) 250 6 23 311 6 29 302 6 28 540 6 50*† 444 6 30*† 330 6 36*† 292 6 25
Isoflurane (%) — 0.40 6 0.03 0.36 6 0.03 0.78 6 0.05† 1.00 6 0.06† 0.91 6 0.07† —
Hemodynamic changes during laparoscopic cholecystectomy and end-tidal isoflurane concentrations: mean arterial pressure (MAP), heart rate (HR), right atrial
pressure (RAP), pulmonary capillary wedge pressure (PCWP), cardiac output (CO), systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) were
measured or calculated before the induction of anesthesia; 10 min after the induction of anesthesia; 10 min after tilting into a 10° head-up position; 5, 15 and 30 min
after the beginning of insufflation; and 30 min after exsufflation. Results are mean 6 SEM. *p , 0.05 compared with before induction; †p , 0.05 compared with head-up
tilt.
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insufflation, and was associated with significant reductions in
intraoperative isoflurane requirements. End-tidal isoflurane
concentrations, 0.4 6 0.1% before PNO in both groups, were
increased to 0.9 6 0.1% in the placebo group but were not
changed in the clonidine group.
Profiles of hemodynamic changes were similar in studies 1
and 2. Clonidine smoothed some of these hemodynamic
changes. Clonidine significantly reduced MAP and HR com-
pared with placebo (Fig. 2). Moreover, clonidine attenuated
the increase in MAP (placebo 128 6 7 mm Hg versus
clonidine 115 6 5 mm Hg, p 5 0.07) and significantly reduces
the increase in SVR (placebo 1745 6 149 dyneszszcm25 versus
clonidine 1394 6 113 dyneszszcm25; p , 0.005) secondary to
peritoneal insufflation after 5 min. However, no significant
differences in absolute values of SVR (Fig. 2) were observed
between the two groups. In both groups SVR did not change
immediately after exsufflation, but it had significantly de-
creased 30 min after exsufflation. At this time point clonidine
significantly reduced the postoperative increase in cardiac
output. Finally, no significant differences in the remaining
hemodynamic parameters (RAP, PCWP, PVR) were observed
in the two groups. Mixed venous blood oxygen saturation
remained normal in both groups intraoperatively. Thirty min-
utes after exsufflation, Sv¯O2 in the clonidine group was .70%
(74 6 2%) and was significantly higher than in the placebo
group (67 6 4%).
Clonidine did not significantly affect the marked release of
vasopressin observed immediately after peritoneal insufflation.
Conversely, plasma concentrations of epinephrine and norepi-
nephrine were significantly reduced in the clonidine group.
Clonidine almost completely blocked the intraoperative in-
crease of norepinephrine. Finally, clonidine had no effect on
cortisol release (Fig. 3).
Discussion
These two studies confirm that peritoneal carbon dioxide
insufflation to an intraabdominal pressure of 14 mm Hg
produces significant hemodynamic changes in healthy patients.
Pneumoperitoneum results in an increase in MAP, SVR and
PVR and a decrease in cardiac output. Heart rate does not
change, or increases only slightly. The increase in SVR is
associated with a marked release of vasopressin and cat-
echolamines. Clonidine given before PNO reduces this release
of catecholamines and provides intraoperative hemodynamic
stability.
Changes in cardiac output. In both studies cardiac output
significantly decreased shortly after the beginning of peritoneal
insufflation. The subsequent increase in cardiac output proba-
bly resulted from surgical stress, as reflected by increased
concentrations of cortisol. Therefore, during PNO for opera-







Surgery5 min 15 min 30 min
PaCO2 (mm Hg) 40.8 6 0.7 37.5 6 1.1* 34.4 6 0.6* 35.9 6 0.8* 39.4 6 0.9 37.9 6 0.8 42.8 6 1.1†
PaO2 (mm Hg) 87 6 3 242 6 11* 210 6 14* 223 6 12* 223 6 12* 212 6 12* 109 6 13
DO2 (mlzmin
21zm22) 635 6 20 523 6 25* 407 6 24* 337 6 23*† 461 6 26* 415 6 26* 612 6 37†
V˙O2 (mlzmin
21zm22) 135 6 9 104 6 5* 105 6 5* 89 6 6* 89 6 5* 94 6 4* 193 6 17*†
SviO2 (%) 75 6 1 81 6 1* 75 6 1 74 6 2 81 6 1* 78 6 1 67 6 2*
Lactate mmolzL21 0.80 6 0.05 0.84 6 0.08 0.96 6 0.07 1.21 6 0.08* 1.44 6 0.09* 1.4 6 0.09* 1.57 6 0.15*
Metabolic changes during laparoscopic cholecystectomy: arterial PCO2 (PaCO2) and PO2 (PaO2), oxygen delivery (DO2), oxygen consumption (V˙O2), mixed venous
blood oxygen saturation (Sv¯O2) and plasma concentration of lactate were measured at the same time points as in Table 1. Results are mean 6 SEM. *p , 0.05 compared
with before induction, †p , 0.05 compared with head-up tilt.
Figure 1. Changes in SVR as well as in plasma concentrations of
vasopressin and neurophysin during laparoscopic cholecystectomy
(study 1). Systemic vascular resistance was calculated and arterial
blood samples were collected before the induction of anesthesia
(PRE-IND); 10 min after the induction of anaesthesia (POST-IND);
10 min after tilting into a 10° head-up position (HEAD-UP); 5 min
(PNP 5), 15 min (PNP 15) and 30 min (PNP 30) after the beginning of
insufflation; and 30 min after exsufflation (END). Results are mean 6
SEM. *p , 0.05 compared with PRE-IND; †p , 0.05 compared with
HEAD-UP.
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tive laparoscopy, impairment of hemodynamic status occurs
mainly at the beginning of peritoneal insufflation. Mixed venous
blood oxygen saturation in both studies, as well as plasma lactate
concentrations in study 1, remained normal intraoperatively.
These findings suggest that changes in cardiac output occurring
during PNO are well tolerated by healthy patients.
Because we only included healthy patients in this study, the
decrease in cardiac output observed during PNO probably
related to a reduction in preload. Pneumoperitoneum results
in caval compression (18), an increase in venous resistance (19)
and pooling of blood in the peripheral circulation (20). All
these effects contribute to decreased venous return. A decline
in venous return was confirmed by a reduction in left ventric-
ular end diastolic volume, measured using transesophageal
echocardiography (21). The paradoxical increase in RAP and
PCWP after insufflation (2,4,22,23) can be explained by the
increased intrathoracic pressure associated with PNO (4,11).
Therefore, during PNO, RAP and PCWP can no longer be
considered reliable indexes of cardiac filling pressures.
Increase in SVR. All studies reported to date describe an
increase in SVR during PNO. This increase in afterload cannot
be simply considered a reflex sympathetic response to de-
creased cardiac output. Indeed, SVR also increased in studies
where no decrease in cardiac output was reported (24,25).
Although the normal heart tolerates increases in afterload
under physiologic conditions, the changes in afterload pro-
duced by PNO can result in deleterious effects in patients with
cardiac diseases and may contribute to a further decrease in
cardiac output (26). The increase in SVR is considered to be
mediated by mechanical and neurohumoral factors (2,4,7), and
the role of mechanical factors might not be predominant.
Indeed, in the second study no changes in SVR were observed
5 min after exsufflation. Instead, correction of these hemody-
namic changes was gradual and took several minutes, suggest-
ing involvement of neurohumoral factors (2,7).
Endocrine correlates of the hemodynamic changes. The
profile of vasopressin release in the first study correlated most
closely with changes in SVR. Induction of PNO resulted in a
rapid and marked release of vasopressin in both studies. This
finding was confirmed by the release of neurophysin. The
longer half-life of neurophysin explains why plasma neurophy-
sin concentrations plateaued after the induction of PNO.
Increases in plasma vasopressin levels were correlated with
changes in intraabdominal pressure, intrathoracic pressure and
transmural RAP (11). Mechanical stimulation of peritoneal
receptors also resulted in increases of vasopressin release (27),
SVR and arterial pressure (28). However, whether increasing
intraabdominal pressure to 14 mm Hg is sufficient to stimulate
these receptors is unknown. Plasma concentrations of vaso-
pressin measured in our two studies were high, and of a
magnitude similar to those reported during acute hemody-
namic stimulation (e.g., massive hemorrhage). This is impor-
tant because vasopressin is a potent vasopressor even at
normal physiologic concentrations (29). Other mediator(s) are
implicated in the increase in SVR. Indeed, although clonidine
did not significantly affect plasma vasopressin concentrations,
it attenuated the increase in SVR.
Catecholamines, and more particularly norepinephrine,
which was also released early during PNO, might contribute to
the increase in afterload. Accordingly, clonidine, which signif-
icantly reduced the release of catecholamines and almost







Surgery5 min 15 min 30 min
Cortisol (mg/ml) 74 6 9 65 6 12 74 6 15 91 6 19 182 6 16*†‡ 248 6 16*†‡ 286 6 25*†‡
Epi. (pg/ml) 68 6 8 44 6 4 46 6 7 183 6 39*† 236 6 55*† 266 6 96*† 389 6 163*†
Norepi. (pg/ml) 241 6 36 241 6 32 295 6 37 410 6 46*† 530 6 72*†‡ 526 6 63*†‡ 508 6 98*†
Renin (pg/ml) 16 6 2 20 6 4 34 6 6* 42 6 7* 53 6 9*†‡ 66 6 11*† 48 6 8†
Endothelin (fmol/ml) 246 6 29 239 6 19 237 6 26 221 6 25 233 6 29 277 6 36 272 6 27
TxB2 (pg/ml) 217 6 34 266 6 25 210 6 32 215 6 36 254 6 34 310 6 37 243 6 40
PGF1a (pg/ml) 204 6 32 211 6 23 162 6 18 149 6 20 198 6 30 178 6 26 165 6 20
PGE2 (pg/ml) 1,090 6 83 1,154 6 113 1,009 6 113 912 6 95 1,275 6 108 1,045 6 92 1,121 6 110
Endocrine changes during laparoscopic cholecystectomy: arterial blood samples were collected at the same time points as in Table 1. The following hormones were
measured: cortisol, epinephrine (Epi), norepinephrine (Norepi), renin, endothelin, a metabolite of thromboxane (TXB2), a metabolite of prostacyclin (6-keto-PGF1a)
and prostaglandin E2 (PGE2). Results are mean 6 SEM. *p , 0.05 compared with before induction, †p , 0.05 compared with head-up tilt; ‡p , 0.05 compared with
pneumoperitoneum 5 minutes.
Table 4. Patient Data (Study 2)
Placebo Clonidine
N 9 11
Age (yrs) 51 6 15 45 6 15
Sex (F/M) 7/2 8/3
Weight (kg) 63 6 8 70 6 17
Height (cm) 164 6 5 162 6 23
PNO duration (min) 80 6 35 67 6 31
Preop. MAP (mm Hg) 96 6 16 99 6 8
Preop. HR (beats/min) 78 6 15 80 6 8
Preop. CO (L/min) 5.4 6 1.5 4.8 6 1.5
Data are mean 6 SD. CO 5 cardiac output; HR 5 heart rate; MAP 5 mean
arterial pressure; PNO 5 pneumoperitoneum. Mean arterial pressure (oscillo-
metric arterial pressure) and heart rate were measured the day before surgery
using a Datex AS/3 monitor. Cardiac output was measured by transthoracic
echocardiography.
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completely blocked norepinephrine release, attenuated the
increase in SVR. The stimulus for catecholamine release
during PNO cannot be determined from these studies. Hyper-
carbia and surgical stress were probably not causes of the
initial increase in epinephrine and norepinephrine because
PaCO2 was kept within physiologic limits, and plasma cortisol
levels had not yet changed at 5 min of PNO in both studies.
The gradual increase in plasma catecholamine concentrations
observed later intraoperatively may be correlated with surgical
stress, as reflected by increasing plasma concentrations of
cortisol, and may contribute to the intraoperative improve-
ment of cardiac output.
In study 1 the plasma concentration of renin was already
increased before insufflation, probably in response to de-
creased venous return secondary to the head-up position and
subsequent hypotension. Five minutes after the beginning of
insufflation, even though SVR had reached its peak, no
significant further increase was observed. The contribution of
renin to the initial increase in afterload is therefore question-
able. During PNO the progressive increase in plasma renin
concentration might be related to activation of the sympathetic
system and to surgical stress (30). Furthermore, renin secretion
may also result from reduction of glomerular filtration and
renal plasma flow induced by PNO (31,32). Finally, prostacy-
clin, PGE2, TxB2 and endothelin did not seem to contribute to
the hemodynamic changes induced by PNO.
Effects of clonidine on hemodynamic and endocrine
changes. In the second study we used clonidine to modulate
hormone release, more particularly catecholamines and vaso-
pressin, with an aim to improving our understanding of the
pathogenesis of the hemodynamic changes induced by PNO.
Clonidine improves intraoperative and postoperative hemody-
namic stability during laparoscopy, similar to what is seen
during general surgery (33,34). Clonidine smoothed the
changes in arterial pressure, HR, SVR and cardiac output.
These benefits are mediated by a reduction of neurohormonal
Figure 2. Effect of 8 mg/kg clonidine infused over 1 h before peritoneal
insufflation on hemodynamic changes induced by carbon dioxide PNO
(study 2). Mean arterial pressure, heart rate, cardiac output and
systemic vascular resistance were measured or calculated at the end of
the infusion of clonidine or placebo and before the creation of the
PNO (PRE-PNO); 5 min after the beginning of peritoneal insufflation
with the patient in the supine position; 15 and 30 min after the
beginning of insufflation with the patient tilted to a 10° head-up
position; 5 min after exsufflation with the patient still tilted to a 10°
head-up position (EXS-5); and finally 30 min after exsufflation,
approximately 15 min after the end of anesthesia and tracheal extu-
bation with the patient in a horizontal position breathing spontane-
ously (END). Results are mean 6 SEM. *p , 0.05 compared with
placebo; †the increase in SVR was significantly (p , 0.05) less in the
clonidine group (1394 6 113 dyneszszcm25) than in the placebo group
(1745 6 49 dyneszszcm25); ‡p , 0.05 compared with PNO 30 min.
Figure 3. Effect of 8 mg/kg clonidine infused over 1 h before peritoneal
insufflation on endocrine changes induced by carbon dioxide PNO
(study 2). Vasopressin, epinephrine, norepinephrine and cortisol were
measured at the same time points as in Figure 2. Results are mean 6
SEM. *p , 0.05 compared with placebo.
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secretion secondary to stress-induced sympathoadrenal hyper-
activation (33–36). Accordingly, plasma catecholamine con-
centrations were significantly lower in the clonidine group.
Inversely, clonidine had no effect on cortisol or vasopressin
release in our study. The effect of clonidine on plasma cortisol
levels seems to be controversial in humans (37–42). However,
stress-induced release of cortisol (40–42), such as during
anesthesia and surgery (42), is not affected by clonidine. The
effect of clonidine on vasopressin secretion is also controversial
(35). Differences in species, route of administration and doses
may explain these discrepancies. Because the characteristics of
vasopressin release depend on the factor triggering its release
(changes in osmolarity, hypovolemia, hypotension, etc.) (43),
the effect of clonidine on vasopressin might also be stimulus
specific. Nevertheless, our findings suggest that high doses of
clonidine given intravenously have no effect on vasopressin
release during laparoscopy. Because clonidine potentiates an-
esthetic agents (33,35,44), isoflurane requirements were signif-
icantly reduced in the clonidine group.
Effects of fluid load on hemodynamic changes. Compari-
son of our two studies confirms the influence of intravascular
volume status on the hemodynamic changes induced by PNO
(19,45,46). Compared with the patients of study 1, patients of
study 2 were preloaded with 500 ml lactated Ringer’s solution,
and insufflation was performed in the supine position instead
of the head-up position. Although cardiac output and SVR
were similar in study 1 after the induction of anesthesia and in
the placebo group of study 2 before induction of PNO (Table
1, Fig. 2), PNO after 5 min resulted in a greater decrease in
cardiac output in study 1 (36 6 5% in study 1 versus 7 6 5%
in study 2) and a higher increase in SVR in study 1 (71 6 9%
in study 1 versus 57 6 10% in study 2). Subsequently, cardiac
output remained lower and SVR greater in study 1 than in
study 2, despite similar levels of anesthesia (isoflurane concen-
trations were similar in both studies). These results provide
further evidence that increasing cardiac filling pressures before
peritoneal insufflation by fluid loading, followed by tilting the
patient to the head-up position only after insufflation, attenu-
ates hemodynamic changes induced by PNO.
In conclusion, the carbon dioxide PNO required for lapa-
roscopy results in multiple hemodynamic changes. These
changes were, however, well tolerated by healthy patients.
Pneumoperitoneum induced increases in arterial pressure and
systemic and pulmonary vascular resistances and a decrease in
cardiac output. Both mechanical (increased intraabdominal
pressure) and humoral factors contributed to these changes.
Vasopressin and catecholamine release probably mediated the
increase in SVR. Clonidine and fluid loading before peritoneal
insufflation attenuated these hemodynamic changes. Further
studies are needed to determine the ideal dose of clonidine.
This information should be helpful in safely managing high-
risk cardiac patients, thereby allowing these patients to benefit
from all the postoperative advantages of the laparoscopic
approach.
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